In situ metabolomics of aldosterone-producing adenomas

Adenoma Adult Male Calcium Channels, L-Type Genotype Hydrocortisone 10265 Clinic for Endocrinology and Diabetology 610 Medicine & health 2700 General Medicine Cohort Studies 03 medical and health sciences Hyperaldosteronism Endocrinology; Hypertension Humans Metabolomics Aldosterone 0303 health sciences Endocrinology ; Hypertension Middle Aged Adrenal Cortex Neoplasms ddc: Phenotype G Protein-Coupled Inwardly-Rectifying Potassium Channels Adrenocortical Adenoma Mutation Steroid 11-beta-Hydroxylase Female
DOI: 10.1172/jci.insight.130356 Publication Date: 2019-09-04T15:01:02Z
ABSTRACT
Recent genetic examinations and multisteroid profiles have provided the basis for subclassification of aldosterone-producing adenomas (APAs). The objective current study was to produce a comprehensive, high-resolution mass spectrometry imaging (MSI) map APAs in relation morphometry, immunohistochemical profiles, mutational status, clinical outcome. cohort comprised 136 patients with unilateral primary aldosteronism. Matrix-assisted laser desorption/ionization–Fourier transform–ion cyclotron resonance MSI conducted, metabolite were analyzed genotype/phenotype information, including digital image analysis from morphometry IHC steroidogenic enzymes. Distinct molecular signatures between KCNJ5- CACNA1D-mutated significant differences 137 metabolites, metabolites purine metabolism steroidogenesis, observed. Intratumor concentration 18-oxocortisol 18-hydroxycortisol inversely correlated staining intensity CYP11B1. Lower CYP11B1 higher levels associated probability complete success after surgery. present demonstrates distinct metabolomic tumor genotype. In addition, we reveal an inverse correlation cortisol derivatives impact on outcome, which provides unprecedented insights into pathophysiology, features, steroidogenesis APAs.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (53)
CITATIONS (33)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....